Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Priming of Multimeric-001 in Elderly
NCT01010737Phase 2Completed
- Sponsor
- Scinai Immunotherapeutics Ltd.
- Start
- Sep 2009
- Primary completion
- Mar 2010
- Modality
- Peptides, Peptide-based Cancer Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of multimeric-001 in influenza, sponsored by Scinai Immunotherapeutics Ltd.. Started Sep 2009; status: completed.
02
Drugs
multimeric-001
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01010737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01010737.